Medication info
Olmesartan Medoxomil 10 mg Tablets

Olmesartan Medoxomil 10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201403399 · Approved 2014.07.25 · Insurance code 625200670

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further reduction in blood pressure is needed, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy and safety of this drug were observed between older and younger patients; however, the possibility of a more sensitive response in some older patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension focuses on controlling blood pressure within the normal range to prevent cardiovascular complications. This medication is used to lower and control blood pressure.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further reduction in blood pressure is needed, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy and safety of this drug were observed between older and younger patients; however, the possibility of a more sensitive response in some older patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn when administered to pregnant women in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to any ingredient in this medication, pregnant or lactating women, patients on dialysis, patients with severe liver dysfunction, patients with biliary obstruction, and certain genetically predisposed lactose intolerant patients should not take this medication. Patients with decreased blood volume or salt may experience hypotension when taking this medication, so their condition should be carefully monitored, and appropriate measures should be taken immediately if hypotension occurs. Patients with severe congestive heart failure or impaired kidney function may experience further deterioration of kidney function when taking this medication, so it should be administered with caution. Patients with poor kidney function or kidney transplant patients should have their blood potassium and creatinine levels monitored regularly when taking this medication, and it is not recommended for patients with severe kidney dysfunction. Patients with aortic or mitral stenosis or obstructive or hypertrophic heart disease require special attention when taking this medication. There is a risk of hyperkalemia, so patients with heart failure or kidney impairment should frequently check their blood potassium levels. Dizziness may occur while taking this medication, therefore, activities requiring alertness, such as operating dangerous machinery or driving, should be avoided. This medication is primarily used for the treatment of hypertension and has been shown to have a tolerability similar to that of a placebo in clinical trials, with side effects generally being mild and transient. The most common side effect is dizziness, while other possible effects include headache, back pain, dyspepsia, palpitations, and rash. Serious side effects such as angioedema, abnormalities in liver function, hyperkalemia, and acute renal failure have been reported, so patients should consult healthcare professionals immediately if unusual symptoms occur. Taking this medication in combination with other antihypertensive agents may enhance the blood pressure-lowering effect, and combining it with potassium-sparing diuretics or potassium supplements may dangerously elevate blood potassium levels. Co-administration with lithium formulations may pose a risk of lithium toxicity, so it is advisable to avoid such combinations. Combined use with non-steroidal anti-inflammatory drugs may increase the risk of renal function deterioration, so caution is needed. Should a pregnant woman take this medication, there are significant risks such as decreased kidney function in the fetus, reduced amniotic fluid, and the development of anomalies, so it must be discontinued immediately upon confirmation of pregnancy. Lactating women should consider stopping breastfeeding or discontinuing the medication, as this drug may be passed into breast milk. Safety and efficacy in pediatric patients have not yet been established, so this drug should be administered to children with caution. Elderly patients may have elevated drug concentrations, requiring dosage adjustment and careful monitoring of their condition. In case of overdose, symptoms such as hypotension and palpitations may occur, requiring immediate treatment. This medication does not pose a carcinogenic risk, even with prolonged use, and has been confirmed as safe in genotoxicity tests.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • indigestion
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated blood creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • elevated blood pressure
  • epistaxis
  • asthma
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be in a cool place between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.